# A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Study · id `cardio:ct-nct04945460` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04945460](<https://clinicaltrials.gov/study/NCT04945460>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04945460

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.

## Technical summary

Registry record NCT04945460. Randomized; triple masking; primary purpose treatment. Start 2021-12-29 (actual); primary completion 2025-09-05 (actual). Results posted on 2026-09-23.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 165 participants (enrolled count; ClinicalTrials.gov record NCT04945460, source copy `cardio:ctgov-nct04945460-2026-09-23`, retrieved 2026-10-31)
- Started: 2021-12-29 (actual) (ClinicalTrials.gov record NCT04945460, source copy `cardio:ctgov-nct04945460-2026-09-23`, retrieved 2026-10-31)
- Primary completion: 2025-09-05 (actual) (ClinicalTrials.gov record NCT04945460, source copy `cardio:ctgov-nct04945460-2026-09-23`, retrieved 2026-10-31)
- Completion: 2026-04-09 (actual) (ClinicalTrials.gov record NCT04945460, source copy `cardio:ctgov-nct04945460-2026-09-23`, retrieved 2026-10-31)
- Results first posted: 2026-09-23 (ClinicalTrials.gov record NCT04945460, source copy `cardio:ctgov-nct04945460-2026-09-23`, retrieved 2026-10-31)
- Countries: United States; Belgium; Canada; France; Germany; Israel; Italy; Mexico; Poland; Spain; Sweden; United Kingdom (ClinicalTrials.gov record NCT04945460, source copy `cardio:ctgov-nct04945460-2026-09-23`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04945460-2026-09-23`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
- Acronym: CADENCE
- Condition: Hypertension, Pulmonary
- Intervention (Drug): Sotatercept 0.3 mg/kg
- Intervention (Drug): Placebo
- Intervention (Drug): Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg
- Lead sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry lists this organization as the lead sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA (`cardio:org-acceleron-pharma-inc-a-wholly-owned-subsidiary-of-merck-co-341e98`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Sotatercept for Combined Post- and Precapillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study (`cardio:pubmed-41904795`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0368e6690cfc36a6c9de638e96010d8e3fa8254b07491aa0e080775785f03ad9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
